Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with advanced cancer. A new ...
Cachexia is a serious yet under-recognized consequence of many chronic diseases, including heart disease, kidney disease, chronic obstructive pulmonary disease and, most notably, cancer.
Pennington Biomedical Research Center is hosting a research trial to determine if the drug Pioglitazone can also be used to treat cachexia, or muscle weakness and weight loss associated with certain ...
The primary endpoint is total lean body mass, and the key secondary endpoints are total body fat mass and physical function as measured by stair climb test at 16 weeks. Topline clinical results ...